Long-term Effect of Intravenous Iron Carboxymaltose Treatment on Oxidative Stress in Women with Iron Deficiency Anemia
HEALTH SCIENCES QUARTERLY · 2021
DOI: 10.26900/hsq.1.1.02 ↗Kurz gefasst
Fachartikel in der Zeitschrift HEALTH SCIENCES QUARTERLY, 2021. Verfasst von Gökhan Pektaş und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
This study aims to clarify the effects of intravenous iron supplementation on biomarkers for oxidative stress in women with iron deficiency anemia.
Methods
This is a cross-sectional review of 40 healthy women and 40 women who underwent intravenous iron treatment due to anemia. Biochemical markers for oxidative stress were determined for both healthy controls and anemic patients. These markers were also evaluated at hour 1 and day 30 of intravenous iron treatment.
Results
The patients with anemia had significantly higher catalase activity and total oxidant status (TOS) but significantly lower nitrate and total anti-oxidant status (TAS) than the healthy controls (p=0.0245, p
Zitieren
APA
Pektaş, G., & Kırlı, İ. (2021). Long-term Effect of Intravenous Iron Carboxymaltose Treatment on Oxidative Stress in Women with Iron Deficiency Anemia. HEALTH SCIENCES QUARTERLY. https://doi.org/10.26900/hsq.1.1.02
Vancouver
Pektaş G, Kırlı İ. Long-term Effect of Intravenous Iron Carboxymaltose Treatment on Oxidative Stress in Women with Iron Deficiency Anemia. HEALTH SCIENCES QUARTERLY. 2021. doi:10.26900/hsq.1.1.02
BibTeX
@article{Pekta2021,
author = {Pektaş, Gökhan and Kırlı, İsmail},
title = {Long-term Effect of Intravenous Iron Carboxymaltose Treatment on Oxidative Stress in Women with Iron Deficiency Anemia},
journal = {HEALTH SCIENCES QUARTERLY},
year = {2021},
doi = {10.26900/hsq.1.1.02}
}
EUVIMED